This year on EHA, we shared exciting new data on Imbruvica® (ibrutinib) in RESONATE-2

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Watch professor Ghia reveal how results from up to 7 years of follow-up reinforce the ground-breaking advance in 1L CLL that Imbruvica represents.[1]

Categories / tags

CP-240988 - June 2021